Intranasal Vaccination with Murabutide Enhances Humoral and Mucosal Immune Responses to a Virus-Like Particle Vaccine

Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype

(2012) Stacey L. Demento et al.   BIOMATERIALS

Long-term patterns of humoral and cellular response after vaccination against influenza A (H1N1) in patients with hematologic malignancies

(2012) Jacopo Mariotti et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Long-Term Maintenance of Polysaccharide-Specific Antibodies by IgM-Secreting Cells

(2011) J. B. Foote et al.   JOURNAL OF IMMUNOLOGY

Vaccination with Liposomal Leishmanial Antigens Adjuvanted with Monophosphoryl Lipid–Trehalose Dicorynomycolate (MPL-TDM) Confers Long-Term Protection against Visceral Leishmaniasis through a Human Administrable Route

(2011) Rajesh Ravindran et al.   MOLECULAR PHARMACEUTICS

Norovirus Vaccine against Experimental Human Norwalk Virus Illness

(2011) Robert L. Atmar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection

(2011) Z. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice

(2011) SriJayaprakash Babu Uppada et al.   VACCINE

Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine

(2011) Lissette S. Velasquez et al.   VACCINE

An Intranasally Delivered Toll-Like Receptor 7 Agonist Elicits Robust Systemic and Mucosal Responses to Norwalk Virus-Like Particles

(2010) L. S. Velasquez et al.   Clinical and Vaccine Immunology

The controversial relationship between NLRP3, alum, danger signals and the next-generation adjuvants

(2010) Roberto Spreafico et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Norwalk virus-like particles as vaccines

(2010) Melissa Herbst-Kralovetz et al.   Expert Review of Vaccines

Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens

(2010) Antu K Dey et al.   Expert Review of Vaccines

Serological Correlate of Protection against Norovirus‐Induced Gastroenteritis

(2010) Amanda Reeck et al.   JOURNAL OF INFECTIOUS DISEASES

Enhanced humoral and cellular immune responses after sublingual immunization against human papillomavirus 16 L1 protein with adjuvants

(2010) Hee-Jeong Cho et al.   VACCINE

TLR, NLR Agonists, and Other Immune Modulators as Infectious Disease Vaccine Adjuvants

(2010) Sarah C. Higgins et al.   Current Infectious Disease Reports

Heterotypic Humoral and Cellular Immune Responses following Norwalk Virus Infection

(2009) L. C. Lindesmith et al.   JOURNAL OF VIROLOGY

Unleashing the therapeutic potential of NOD-like receptors

(2009) Kaoru Geddes et al.   NATURE REVIEWS DRUG DISCOVERY

Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors

(2008) Szilvia Benkő et al.   BIOLOGICAL CHEMISTRY

NOD-like receptors (NLRs): bona fide intracellular microbial sensors

(2008) Michael H Shaw et al.   CURRENT OPINION IN IMMUNOLOGY

Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells

(2008) Mirjam Kool et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

(2008) Stephanie C. Eisenbarth et al.   NATURE